Skip to content

Clinical trials

Phase 3 Pulmonary Disease, Chronic Obstructive trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 3 Country / region: Australia Clear all

57 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20021
20033
20064
20083
20095
20103
20115
20123
20133
20145
20152
20164
20192
20202
20211
20222
20232
20241
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed47
Recruiting5
Active, not recruiting2
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim13
GlaxoSmithKline12
AstraZeneca11
Novartis Pharmaceuticals5
Pearl Therapeutics, Inc.3
Hoffmann-La Roche2
Novartis2
Sanofi2
Baxalta now part of Shire1
Broncus Technologies1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive57
Bronchitis, Chronic3
Emphysema3
Cardiovascular Diseases2
Dyspnea2
Lung Diseases2
Asthma1
Bronchial Diseases1
Lung Diseases, Obstructive1
Respiratory Tract Diseases1

Trials

Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.